Overview

A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone

Status:
Completed

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

Summary

This trial is conducted in Europe. The aim of this clinical trial is to investigate the safety, tolerability, pharmacokinetics (the determination of the concentration of the administered medication in blood over time) and pharmacodynamics (the determination of the effect over time and the duration of action) of a long-acting growth hormone (NNC126-0083) in growth hormone deficient children.

Phase:

Phase 2

Details

Lead Sponsor:

Novo Nordisk A/S

Treatments:

Hormones